4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Ypsomed Holding AG (YPSN) operates in the Medical Instruments & Supplies industry and is headquartered in Burgdorf, Switzerland with about 2,025 employees. Its market capitalization is roughly CHF 5 billion. In the fiscal year ended 2026-03-31, YPSN reported CHF 731M in revenue and CHF 222M in net income.
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | CHF 731M | CHF 749M | CHF 548M | CHF 498M | — |
| Gross Profit | CHF 315M | CHF 292M | CHF 220M | CHF 141M | — |
| Operating Income (EBIT) | CHF 246M | CHF 113M | CHF 86M | CHF 61M | — |
| Net Income | CHF 222M | CHF 88M | CHF 78M | CHF 51M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CHF 30M) | (CHF 27M) | (CHF 18M) | (CHF 8M) | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | CHF 1.3B | CHF 1.3B | CHF 1.1B | CHF 862M | — |
| Total Liabilities | CHF 598M | CHF 651M | CHF 476M | CHF 300M | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive YPSN viewer.
About TickerBase · Data methodology & sources · Privacy · Terms